Insights from 2023 ESMO Asia Annual Meeting
Gynecologic
Insights from 2023 ESMO Asia Annual Meeting
LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent Clear Cell Gynecological Cancer
FEATURING
Natalie Ngoi
- 191 views
- February 13, 2024